donation
To request Mental Health
Services or to access Mental
Health Crisis Services Call:
1-800-375-4357

Cancer
Resources
Basic InformationLatest News
Health Tip: Considering Genetic Testing For Cancer?Bug Behind Stomach Cancer Also Linked to Colon CancerObesity Doubles Odds for Colon Cancer in Younger WomenDon't Overlook Heart Care After Cancer DiagnosisFour Myths About Breast Cancer DebunkedDoes Aspirin Help Prevent Liver Cancer?Health Tip: Living With Cancer For YearsLow-Dose Aspirin May Protect Against Ovarian Cancer: StudyAlzheimer's Gene Tied to 'Chemo Brain' in Breast Cancer SurvivorsCould Diet Affect Breast Cancer Risk?New Treatment Approved for Common Skin CancerTherapeutic Vaccine Shows Promise Against a Range of CancersDoctors Use Bacteria as Weapon Against CancerPatients Want Breast Cancer Costs UpfrontMost People Don't Know if They Have Genetic Risk for CancerBreast Cancer Treatment Adherence Rates Vary by Race5 Facts Every Woman Should Know About Ovarian CancerLook for Early Signs of Thyroid Cancer, Experts UrgeHealth Tip: Identifying Risk Factors for Prostate CancerNovel Treatment Approved for 'Hairy Cell' LeukemiaCancer Advances Rely on U.S. Funding: ReportHealth Tip: Understanding Mouth Issues During Cancer TreatmentGoing Vegetarian to Cut Colon Cancer RiskChemo for Lung Cancer May Trigger Early Menopause, Study FindsMany Who Battle Cancer Stay Strong MentallyWhat Every Woman Needs to Know About Ovarian CancerIs Teen Drinking Tied to Aggressive Prostate Cancer Later in Life?Health Tip: Talking About Your Cancer DiagnosisBills Mount for Breast Cancer SurvivorsDrug Combo Fights Melanoma That Has Spread to BrainWhy Fewer Blacks and Hispanics Survive Some Childhood CancersStudy Explores New Way to Stop Cancer's SpreadBlood Test Gives Quick Prognosis for Lymphoma Treatment: StudyRadiation for Childhood Brain Tumor Can Hinder MemoryClinical Trials Balance Out Urban, Rural Cancer Survival RatesGenetic Testing for Cancer Lacking for Women on Medicare: StudyBreast Cancer Drug Promising in Phase 3 TrialLack of Exercise Can Boost Cancer RiskLung Cancer Screening's Downside Not Discussed EnoughFrequent Skin Cancers May Signal Risk of Other Cancers, TooNew Treatment for Non-Hodgkin Lymphoma ApprovedTriple-Negative Breast Cancer Genes ID'dHeart Monitoring a Must for Breast Cancer Patients on HerceptinTo Boost Colon Cancer Screening, Use the MailAzedra Approved for Rare Adrenal TumorsToo Few Americans Getting Screened for Cancer: CDCYes, Fingernail Cancer Is a Thing -- Just Ask This Beauty QueenWhy Are Doctors Removing Too Many Thyroids?Health Tip: Exercise May Lower Your Risk of CancerLarge U.S. Study Targets Prostate Cancer in Black Men
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Acupuncture May Ease Pain Tied to Breast Cancer Care

HealthDay News
by -- Robert Preidt
Updated: Dec 7th 2017

new article illustration

THURSDAY, Dec. 7, 2017 (HealthDay News) -- Some common breast cancer medications can trigger joint pain, but new research suggests acupuncture may ease that side effect.

The finding could be a win-win for breast cancer patients, said one oncologist who reviewed the study.

"Acupuncture has been around for thousands of years and has no real downside," said Dr. Lauren Cassell, chief of breast surgery at Lenox Hill Hospital in New York City.

"If something so simple as acupuncture can improve upon these symptoms and the patients' quality of life, we will have more women becoming compliant in taking their medication, and one would expect improved outcomes," Cassell added.

The new study was led by Dr. Dawn Hershman, who heads the Breast Cancer Program at NewYork-Presbyterian/Columbia University Medical Center, also in New York City.

Hershman's team tracked outcomes for 226 postmenopausal women with early stage breast cancer who were taking drugs called aromatase inhibitors.

These drugs -- which include Arimidex, Femara and Aromasin, among others -- are often used to treat women with estrogen-sensitive breast tumors, Hershman said.

But she added that "many patients suffer from side effects that cause them to miss treatments or stop treatment altogether. We need to identify strategies to control these side effects, the most common of which is debilitating joint pain and stiffness."

Hershman's team wondered if the ancient practice of acupuncture might help. Of the patients in the study, 110 received true acupuncture, 59 were given fake acupuncture (needles placed at ineffective spots on the body), and another 57 were placed on a waiting list.

The patients in the true and fake acupuncture groups underwent twice-weekly sessions for six weeks, followed by one session a week for six more weeks.

After six weeks, patients in the true acupuncture group reported much lower pain scores than those in either the fake acupuncture or waiting list groups, Hershman's team reported.

The study was scheduled for presentation Thursday at the annual San Antonio Breast Cancer Symposium, in Texas.

The finding may mean that women with pain related to aromatase inhibitor use might stick to their meds longer if acupuncture eases their joint pain, "but we need to conduct further studies to determine if this is indeed the case," Hershman said in a meeting news release.

In the meantime, the findings suggest that "health care practitioners should discuss the possibility of acupuncture with patients experiencing aromatase inhibitor-related joint pain and stiffness, because it has the potential to improve their quality of life," Hershman said.

Dr. Cynara Coomer directs the Florina Rusi-Marke Comprehensive Breast Center, at Staten Island University Hospital in New York City. Reading over the findings, she agreed that "the integration of Western and Eastern medicine is an important path to explore" in breast cancer care.

And with an opioid-addiction crisis sweeping the United States, "it is important for physicians to find other means of pain control for our patients," she added.

"This is yet another study that reveals the benefits of acupuncture in treating pain," Coomer said.

Study findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.

More information

Breastcancer.org has more on aromatase inhibitors.